Meet us at NLSDays

In the south of Stockholm you’ll find Flemingsberg, home to a vibrant life science cluster that’s rapidly emerging as an attractive location for life science companies to establish. Here, academia, business and society form a dynamic ecosystem, fueling innovation and growth. And with more companies establishing and collaborations further deepening, the opportunity to expand and invest have never been greater. This year, we are therefore participating in NLSDays in Gothenburg, where we will showcase Flemingsberg’s unique strengths and invite more stakeholders to become part of our thriving life science environment.

World-class infrastructure and knowledge

Flemingsberg is a gateway to one of Sweden’s most complete life science ecosystems – combining access to top-tier research, a growing cluster of innovative companies and unbeatable proximity to healthcare. Here, you’ll find Europe’s best hospital, five colleges and an upper secondary school. A stone’s throw away is Novum Research Park, hosting the innovative co-working concepts Novum Labs and The Park, and neighbors such as NextCell Pharma, Circio, Sprint Bioscience and AlzeCure Pharma. Another stone’s throw away lies Alfred Nobels allé, with three prime locations at a total of 15,172 square meters, ready to be transformed into facilities for life science companies.

From idea to success

Whether you’re expanding into the Nordics or scaling globally, Flemingsberg offers the environment, support and partnerships to help you succeed from day one. Actively supporting both existing and new companies is also Flemingsberg Science Foundation. Through the three-year ERDF-funded project Life Science Cluster Flemingsberg, they are boosting the growth and establishment of small and medium-sized enterprises.

“We work with developing the cluster by creating the right conditions for companies to grow, establish themselves, and become part of our thriving community,” says Natasha Bank, Cluster Manager at Flemingsberg Science Foundation.

A growing urban city

Flemingsberg is also one of the designated urban centers in the Stockholm region. With the ambitious goal of 50,000 residents, 50,000 workers, and 50,000 daily visitors, Flemingsberg is developing into a vibrant urban city. With new housing being built, modern offices and lab spaces, and only 19 minutes to central Stockholm – Flemingsberg is perfectly positioned for both business and lifestyle.

“Science never sleeps, and neither does Flemingsberg. Here, everything is possible – with a thriving ecosystem, world-class research, and innovation-ready infrastructure all in place. Get in touch, we’ll help you take the next step!”

At NLSDays, you’ll find us at the Flemingsberg booth alongside representatives from the real estate companies Fabege and Hemsö. See you at booth B02:24.

Flemingsberg Science Foundation 2024 – New Opportunities Through Partnerships

As the year comes to an end, it is time to reflect and summarize our progress. We are now concluding year three of our four-year strategic period. Are we moving in the right direction to ensure that Flemingsberg becomes the obvious choice for establishments in southern Stockholm, offering a world-class innovation environment?

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

Go to Top